What are the treatment options for multiple myeloma (MM) in patients with progressive or relapsing disease following autologous stem-cell transplantation?

Updated: Jul 15, 2019
  • Author: Dhaval Shah, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

In MM patients with progressive or relapsing disease following autologous stem-cell transplantation, treatment with the combination of bortezomib, thalidomide and dexamethasone is more effective than treatment with thalidomide and dexamethasone alone, although triple therapy is associated with a greater risk of grade 3 neurotoxicity. [111]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!